Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

RT @ramos262740691: 【危険信号】 さて、cdcが出した二価ワクのVE速報 https://t.co/haEsT9LbGx

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

RT @ramos262740691: 【危険信号】 さて、cdcが出した二価ワクのVE速報 https://t.co/haEsT9LbGx

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 https://t.co/YA74ekqLM1 上記の報告内に出てくる表を貼り付けます。 https://t.co/9Tc6gmQy2o

RT @Neoavatara: "A study from the Centers of Disease Control and Prevention showed that 18- to- 49-year-olds who received the most recent b…

RT @ramos262740691: 【危険信号】 さて、cdcが出した二価ワクのVE速報 https://t.co/haEsT9LbGx

RT @ramos262740691: 【危険信号】 さて、cdcが出した二価ワクのVE速報 https://t.co/haEsT9LbGx

RT @ramos262740691: 【危険信号】 さて、cdcが出した二価ワクのVE速報 https://t.co/haEsT9LbGx

RT @Neoavatara: "A study from the Centers of Disease Control and Prevention showed that 18- to- 49-year-olds who received the most recent b…

"A study from the Centers of Disease Control and Prevention showed that 18- to- 49-year-olds who received the most recent bivalent booster showed a 43 percent decrease in infection. However, that paper only studied the first two months after vaccination."

RT @Alzhacker: CDCは 11月22 日、二価ワクチンの効果に関する最初の研究 結果を発表した。https://t.co/Ge5cE4tWrV 研究の著者は、この結果は「未接種者はワクチン接種者と比較して、COVID-19を獲得するための異なる行動や根本的に異なる…

@go_go_g_o @mph_for_doctors これ読むべし。前回も言ったけど、情報が正しいか、見比べることが大事です。 https://t.co/8zEsEk2XnU.

CDCは 11月22 日、二価ワクチンの効果に関する最初の研究 結果を発表した。https://t.co/Ge5cE4tWrV 研究の著者は、この結果は「未接種者はワクチン接種者と比較して、COVID-19を獲得するための異なる行動や根本的に異なるリスクを持っているかもしれず、注意して解釈すべきだ」と正しく述べている。

RT @brtatsu: https://t.co/uIUZaoPXwQ

@Glenandjojo @jeremygoepel @ViralNewsNYC Here: https://t.co/KovdHwrydK Here: https://t.co/ogPx2JW9Lf (Have to download a pdf to see the full study) I'll take what these studies show and see the benefit

@tomazzogalando @bmason1270 @jhunter101 @elonmusk They quite literally have… https://t.co/G4FKHnsagg

@burnthisplacee @longest_cat @dancoyro @RitchieTorres https://t.co/skoBUuHGHO

@burnthisplacee @DJdroidzilla22 @longest_cat @dancoyro @RitchieTorres https://t.co/skoBUuHGHO

https://t.co/uIUZaoPXwQ

RT @Scary7Dr: @doom37455413 @AndrewLazarus4 @LouforFreedomL1 @TonyBaduy @mcfunny @provaxtexan @JimeeLiberty @SkepticalMutant @Pouldeau61 @M…

@doom37455413 @AndrewLazarus4 @LouforFreedomL1 @TonyBaduy @mcfunny @provaxtexan @JimeeLiberty @SkepticalMutant @Pouldeau61 @MaureenStroud @richykirsh @nopoisonjabs @BurgerLab12 @nuhope2022 @JKelleyK @Thskicksarefire @IdunsDaughter @scottstocker4 @JohannaSz

RT @TracyBethHoeg: Oh boy. @CDCgov released data on the new bivalent booster & it doesn't look good at 2-3 months. They used test negative…

RT @TracyBethHoeg: Oh boy. @CDCgov released data on the new bivalent booster & it doesn't look good at 2-3 months. They used test negative…

RT @TracyBethHoeg: Oh boy. @CDCgov released data on the new bivalent booster & it doesn't look good at 2-3 months. They used test negative…

RT @TracyBethHoeg: Oh boy. @CDCgov released data on the new bivalent booster & it doesn't look good at 2-3 months. They used test negative…

RT @TracyBethHoeg: Oh boy. @CDCgov released data on the new bivalent booster & it doesn't look good at 2-3 months. They used test negative…

RT @TracyBethHoeg: Oh boy. @CDCgov released data on the new bivalent booster & it doesn't look good at 2-3 months. They used test negative…

RT @TracyBethHoeg: Oh boy. @CDCgov released data on the new bivalent booster & it doesn't look good at 2-3 months. They used test negative…

RT @F3_Haskell: @RBarker0341 @BlaylockMooky @LauriHWilliams @Tdillon06 @andrew7rd @CoryRove @krazykitkatm @Michael94173566 @Ravi1236541 @DH…

RT @F3_Haskell: @RBarker0341 @BlaylockMooky @LauriHWilliams @Tdillon06 @andrew7rd @CoryRove @krazykitkatm @Michael94173566 @Ravi1236541 @DH…

@RBarker0341 @BlaylockMooky @LauriHWilliams @Tdillon06 @andrew7rd @CoryRove @krazykitkatm @Michael94173566 @Ravi1236541 @DHasper @mjoyce1950 @ADevotedYogi @delboy00789 @GeezercitizenX @cha0te @mpc_xetts @IRONSal1 @skullapple27 @dray3time @LifechoiceN @umfp

RT @TracyBethHoeg: Oh boy. @CDCgov released data on the new bivalent booster & it doesn't look good at 2-3 months. They used test negative…

RT @TracyBethHoeg: Oh boy. @CDCgov released data on the new bivalent booster & it doesn't look good at 2-3 months. They used test negative…

RT @KitsapHealth: A new CDC study found that bivalent boosters provided significant additional protection against COVID-19 illness for peop…

A new CDC study found that bivalent boosters provided significant additional protection against COVID-19 illness for people who had received two, three, or four monovalent (original) vaccine doses: https://t.co/TbpAohSR7b Find local vaccine appointments at

Apparently, 4 shots for me is sufficient. Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 https://t.co/QZwpHY5tq6

引用したツイートとその前後の話題について，元の報告は CDC によるこれか。きあいいれてよんでみるか……。 https://t.co/fSI0dFRf0y

bivalent boosters provided significant additional protection云々って書かれてますが。内容読んでますか?

@mph_for_doctors うーん最近CDCがブースター意味なさそうな記事出してますけどね。 これどう思いますか？ https://t.co/jfPIAbOxYj

@OLVR15583405 @MicheleN1L @SIfill_ @jack They still died. The vaccine may have initially helped. But the vaccine's efficacy rate is under 30% now. He is still saying it works because it helps him get paid more. Do you think that 30% is a good gamble??? Her

Wichtig: Diese 🇬🇧-Daten sagen nur bedingt etwas darüber aus, ob/wie stark die [Original & BA.1]-Booster weniger wirksam als die [Original & BA.4/5]-Booster sind. Es gibt keine direkten Vergleiche. Die Wirksamkeit letzterer ist aber auch bereits bel

@draccah @matthewdmarsden https://t.co/skoBUuHGHO

@draccah @matthewdmarsden https://t.co/skoBUuHGHO

@matthewdmarsden https://t.co/skoBUuHGHO

@Izuke47 @streets_a_head @longest_cat @dancoyro @RitchieTorres https://t.co/skoBUuHGHO

@burnthisplacee @longest_cat @dancoyro @RitchieTorres https://t.co/skoBUuHGHO

RT @angie_rasmussen: Lots of chatter about how @CDCgov finally said the word “mask” after X many months. But a lot less talk about this s…

@EricTopol @CarlaKJohnson @laura_ungar @AP @APHealthScience For those interested, the relative VE (rVE) for preventing symptomatic COVID infection for those 65 years or older: Where 2–3 months had elapsed since the last monovalent dose was 28% Where ≥8 mon

@leonor_cordeiro @mellziland @stephanevw @import_robs I'm not Mel but the relative VE (rVE) for preventing symptomatic COVID infection for those 65 years or older: Where 2–3 months had elapsed since the last monovalent dose was 28% Where ≥8 months had elap

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means the vacc…

RT @angie_rasmussen: This study shows that bivalent boosters significantly improved vaccine effectiveness against symptomatic infection, wi…

RT @ramos262740691: 【危険信号】 さて、cdcが出した二価ワクのVE速報 https://t.co/haEsT9LbGx

RT @angie_rasmussen: Lots of chatter about how @CDCgov finally said the word “mask” after X many months. But a lot less talk about this s…

RT @angie_rasmussen: Lots of chatter about how @CDCgov finally said the word “mask” after X many months. But a lot less talk about this s…

RT @yoongkhean: Some real world data from the bivalent vaccine against #COVID19. https://t.co/KXlMHNWEE8

RT @yoongkhean: Some real world data from the bivalent vaccine against #COVID19. https://t.co/KXlMHNWEE8

RT @yoongkhean: Some real world data from the bivalent vaccine against #COVID19. https://t.co/KXlMHNWEE8

RT @yoongkhean: Some real world data from the bivalent vaccine against #COVID19. https://t.co/KXlMHNWEE8

Some real world data from the bivalent vaccine against #COVID19. https://t.co/KXlMHNWEE8

RT @ramos262740691: 【危険信号】 さて、cdcが出した二価ワクのVE速報 https://t.co/haEsT9LbGx

RT @sailorrooscout: @AshberryOlivia We don’t fully know that just yet but do remember that immunological memory still plays a huge part too…

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means the vacc…

RT @ramos262740691: 【危険信号】 さて、cdcが出した二価ワクのVE速報 https://t.co/haEsT9LbGx

RT @ramos262740691: 【危険信号】 さて、cdcが出した二価ワクのVE速報 https://t.co/haEsT9LbGx

RT @ramos262740691: 【危険信号】 さて、cdcが出した二価ワクのVE速報 https://t.co/haEsT9LbGx

RT @ramos262740691: 【危険信号】 さて、cdcが出した二価ワクのVE速報 https://t.co/haEsT9LbGx

@dankennedy_nu @nytimes https://t.co/AfKWtoKXRU.

RT @kyledalyfagan: @AlexBerenson https://t.co/TddEbrGY6h

@AlexBerenson https://t.co/TddEbrGY6h

@JediTigger @NikkiMcR @brendanhunting https://t.co/NDTtkXBqbH

RT @celinegounder: 1/ @CDC released a new @MMWR report today on the effectiveness of the updated bivalent COVID boosters. https://t.co/xhd…

RT @ramos262740691: 【危険信号】 さて、cdcが出した二価ワクのVE速報 https://t.co/haEsT9LbGx

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means the vacc…

RT @angie_rasmussen: This study shows that bivalent boosters significantly improved vaccine effectiveness against symptomatic infection, wi…

https://t.co/48FyOLMLHR

@NicoVedrines @UnionSanitaire @UnionPompiers @Union_Etudiants @SyndicatSLS @MartinBlachier @gkierzek @AliceDesbiolles @alainhoupert @noel_sylviane @J_Bardella @CarolineFiat54 @Republicains_An @socialistesAN @deputesPCF @DeputesDem @DeputesRE @Horizons_AN @

RT @morilyn1123: なお、オミクロン用2価ワクチンの発症予防効果はかなり限定的で、データを見る限り従来型を追加接種した時とそう変わりません。ですので、初回から接種できるようになっても特にインパクトはなさそうな… というか、最初から接種するとなると免疫の誘導され方も…

@ThothCatalog @EricTopol @latimes @latimesopinion You call this working? 28% to 31% RVE? That's probably including the BA 5 variant. If just the latest BA Q variants are included, it might even be lower. It's not what was hoped from the bivalent vacc

@gunvals @EricTopol @OurWorldInData He doesn't seem to answer pertinent questions. The recent 12/2 CDC study indicated the RVE of the bivalent booster is about 28% for the over 65 group. Maybe lower if just the current BA Q variants were included? https

@43blah @JenniferNuzzo @notdred https://t.co/wegyiwvcDM

@DrFranckClarot @StephaneKM L’etude en question en pj. A lire avt. Bourrée de biais, très faible niveau de preuve. Malhonnête car parle de tx relatif et non absolue… Etude tte pourrie, etude trompeuse https://t.co/nf70ICn3y0

he're some details about what the Bivalent Booster is, and why it's important to stay up to date with your vaccination history https://t.co/B9Sudu64Pc

@Liteinthedark2 Here’s a report indicating the efficacy of the bivalent booster. Bear in mind this is for current variants. As the virus continues to mutate, both the vaccine & infection from current strains will provide less immunity. https://t.co/X4R

@festinalenteaaa @haase_jackie @AnneofKingston @CTVNews Stay on topic muffin, we don't have time for you to get distracted. Here's the first study: I'll give you a minute to read it over https://t.co/r37Wic1tsC.

Une arnaque bien ficelée à propos des vaccins bivalents https://t.co/nl9K0midRS par Eric. Le lien vers ce torchon du Centre de Désinformation Continue :  https://t.co/jjgIUU32aq @SchoofsLiliane @GMeyfroidt @YvesCoppieters @LeilaBelk